MiMedx Group financials
$4.67−0.21%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $418.6M | $348.9M | $321.5M | $267.8M | $242.0M | $248.2M | $299.3M | $359.1M | $321.1M | $221.7M |
| Gross profit | $345.6M | $288.8M | $266.8M | $219.5M | $202.4M | $208.9M | $256.2M | $322.7M | $285.9M | $190.8M |
| Gross margin | 82.6% | 82.8% | 83.0% | 82.0% | 83.6% | 84.2% | 85.6% | 89.9% | 89.0% | 86.0% |
| Operating income | $63.9M | $59.3M | $37.1M | -$14.7M | -$7.1M | -$45.4M | -$21.2M | -$3.9M | $46.2M | $884.0K |
| Net income | $48.6M | $42.4M | $58.2M | -$30.2M | -$18.4M | -$83.3M | -$25.6M | -$30.0M | $64.7M | $390.0K |
| Net margin | 11.6% | 12.2% | 18.1% | −11.3% | −7.6% | −33.6% | −8.5% | −8.3% | 20.2% | 0.2% |
| Diluted EPS | $0.32 | $0.28 | $0.37 | $-0.33 | $-0.17 | $-0.77 | $-0.24 | $-0.28 | $0.56 | $0.00 |
| EBITDA | $78.8M | $65.4M | $40.5M | -$10.7M | -$826.0K | $22.9M | $53.4M | $54.3M | $52.0M | $6.4M |
| Operating cash flow | $74.0M | $66.2M | $26.8M | -$17.9M | -$2.0M | -$30.3M | -$36.7M | $36.6M | $66.5M | $25.5M |
| Free cash flow | $73.0M | $64.5M | $24.8M | -$19.4M | -$5.2M | -$34.5M | -$38.4M | $27.2M | $61.4M | $19.3M |
| Diluted shares | 149.7M | 149.0M | 146.0M | 112.9M | 110.4M | 108.3M | 106.9M | 105.6M | 116.1M | 112.6M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $166.1M | $104.4M | $82.0M | $66.0M | $87.1M | $95.8M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — | — |
| Total debt | $18.0M | $18.8M | $49.1M | $48.6M | $48.1M | $47.7M |
| Total assets | $342.7M | $263.9M | $239.0M | $171.4M | $187.9M | $202.0M |
| Total liabilities | $86.1M | $70.8M | $96.3M | $96.9M | $95.4M | $110.6M |
| Shareholders' equity | $256.5M | $193.1M | $142.7M | -$18.0M | $82.0K | -$150.0K |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology